Convergence of Pre- and Postsynaptic Influences on Glucosensing Neurons in the Ventromedial Hypothalamic Nucleus
- 1Department of Pharmacology and Physiology, New Jersey Medical School (UMDNJ), Newark, New Jersey
- 2Department of Neurosciences, New Jersey Medical School (UMDNJ), Newark, New Jersey
- 3Neurology Service (127C), Veterans Administration Medical Center, East Orange, New Jersey
Abstract
Glucosensing neurons in the ventromedial hypothalamic nucleus (VMN) were studied using visually guided slice-patch recording techniques in brain slices from 14- to 21-day-old male Sprague-Dawley rats. Whole-cell current-clamp recordings were made as extracellular glucose levels were increased (from 2.5 to 5 or 10 mmol/l) or decreased (from 2.5 to 0.1 mmol/l). Using these physiological conditions to define glucosensing neurons, two subtypes of VMN glucosensing neurons were directly responsive to alterations in extracellular glucose levels. Another three subtypes were not directly glucose-sensing themselves, but rather were presynaptically modulated by changes in extracellular glucose. Of the VMN neurons, 14% were directly inhibited by decreases in extracellular glucose (glucose-excited [GE]), and 3% were directly excited by decreases in extracellular glucose (glucose-inhibited [GI]). An additional 14% were presynaptically excited by decreased glucose (PED neurons). The other two subtypes of glucosensing neurons were either presynaptically inhibited (PIR; 11%) or excited (PER; 8%) when extracellular glucose was raised to >2.5 mmol/l. GE neurons sensed decreased glucose via an ATP-sensitive K+ (KATP) channel. The inhibitory effect of increased glucose on PIR neurons appears to be mediated by a presynaptic γ-aminobutyric acid–ergic glucosensing neuron that probably originates outside the VMN. Finally, all types of glucosensing neurons were both fewer in number and showed abnormal responses to glucose in a rodent model of diet-induced obesity and type 2 diabetes.
Footnotes
-
Address correspondence and reprint requests to Vanessa H. Routh, Department of Pharmacology & Physiology, New Jersey Medical School (UMDNJ), 185 S. Orange Ave., Newark, NJ 07103. E-mail: routhvh{at}umdnj.edu.
Received for publication 8 June 2001 and accepted in revised form 20 September 2001.
ACSF, artificial cerebrospinal fluid; CFTR, cystic fibrosis transmembrane regulator; DIO, diet-induced obesity; DR, diet-resistant; GABA, γ-aminobutyric acid; GABAA, GABA type A; GE, glucose-excited; GI, glucose-inhibited; GR, glucose-responsive; GS, glucose-sensitive; KATP, ATP-sensitive K+ channel; PED, presynaptically excited by decreased extracellular glucose; PER, presynaptically excited when extracellular glucose was raised; PIR, presynaptically inhibited when extracellular glucose was raised; RMP, resting membrane potential; SUR, sulfonylureas receptor; VMN, ventromedial hypothalamic nucleus.











